You are here

Advisors

 

PRF Editorial Board

 

Theodore (Ted) Price, PhD, is Chair of the PRF Editorial Board. He is the Eugene McDermott Professor and Director of the Systems Neuroscience Program in the School of Behavioral and Brain Sciences at University of Texas (UT) at Dallas. He is also the Director of the Center for Advanced Pain Studies at UT Dallas. He did his PhD work with Chris Flores and Ken Hargreaves at UT Health San Antonio and a postdoctoral fellowship at McGill University with Fernando Cervero. He started his independent laboratory in 2007 at University of Arizona School of Medicine and moved to UT Dallas in 2014. His lab is interested in molecular mechanisms driving the transition to chronic pain with a focus on drug development for chronic pain disease modification and on peripheral and central mechanisms of neuronal plasticity in response to injury. He has won numerous awards including the John C. Liebeskind Early Career Scholar Award from the American Pain Society and the Patrick D. Wall Young Investigator Award from the International Association for the Study of Pain. Ted serves on editorial boards for leading pain and neuroscience journals such as PAIN and Journal of Neuroscience, and is a standing member of the Somatosensory and Pain Study Section for NIH.

Fumimasa Amaya, MD, PhD, is an associate professor in the Department of Pain Management and Palliative Care Medicine, and a principal investigator in the Research Unit for the Neurobiology of Pain in the Department of Anesthesiology at Kyoto Prefectural University of Medicine in Japan. His research career focused on pain medicine began in 1998 when he joined the Neural Plasticity Research Group in the Department of Anesthesiology, Massachusetts General Hospital, Boston, US, under Dr. Clifford Woolf, to investigate the expression of Nav1.8 and Nav1.9 in the dorsal root ganglion and to analyze the behavioral phenotype of Nav1.9 knockout mice. After returning to Kyoto, Dr. Amaya continued his research on primary afferent neurons, and extended it to encompass pain mechanisms involved after surgery. He reported that primary afferent neurons undergo a change in phenotype after tissue injury. These observations help to explain the distinctive characteristics of pain after surgery. His group is conducting several research projects right now. They include 1) peripheral mechanisms of pain chronicity after surgery, 2) function of primary afferent neurons as detectors of PAMPs/DAMPs, and 3) contribution of mitochondrial stress to the development of pathological pain. He is also conducting clinical studies to investigate the prevalence of and risk factors for chronic pain after surgery. His goal is to integrate his findings from basic research and clinical study to provide better pain management. 

 

Allan Basbaum, PhD, FRS, is a professor and chair of the Department of Anatomy at the University of California, San Francisco, US. From 2003 to 2012, he served as the editor-in-chief of PAIN, the journal of the International Association for the Study of Pain (IASP). He is a recipient of the Frederick W.L. Kerr Basic Science Research Award from the American Pain Society and the Bristol-Myers Squibb Prize for Distinguished Pain Research. Dr. Basbaum is a member of the American Academy of Arts and Sciences, the US National Academy of Medicine (formerly called the Institute of Medicine), and the British Academy of Medical Science. He is also a Fellow of the Royal Society in the UK. Dr. Basbaum’s research examines the mechanisms through which tissue and nerve injury produce changes in the peripheral and central nervous system, resulting in persistent pain. In parallel studies, his lab is examining the circuits through which pruritogens generate itch.

M. Catherine Bushnell, PhD, is scientific director of the Division of Intramural Research at the National Center for Complementary and Integrative Health (NCCIH; formerly NCCAM) at the US National Institutes of Health, Bethesda, US, where she oversees a program on the brain’s role in perceiving, modifying, and managing pain. Prior to her appointment at NCCAM in 2012, Dr. Bushnell was the Harold Griffith Professor of Anesthesia at McGill University in Montreal, Canada. She has been president of the Canadian Pain Society, and press editor-in-chief of the International Association for the Study of Pain. Among her other honors are the Lifetime Achievement Award from the Canadian Pain Society, and the Frederick W.L. Kerr Basic Science Research Award from the American Pain Society. Her research interests include forebrain mechanisms of pain processing, psychological modulation of pain, and neural alterations in chronic pain patients. Recent projects have utilized brain imaging and psychophysical testing to study the neural basis of pain processing, addressing both normal pain processing and aberrant processing after nervous system damage.

Margarita Calvo, PhD, is an assistant professor at the Department of Physiology at Pontifical Catholic University of Chile, Santiago, where she undertook her medical training. Dr. Calvo was awarded her PhD in 2010 by King’s College London, UK, working in Professor David Bennett’s lab. She returned to Chile in 2013, where she set up her own lab. She is working in two lines of research: painful small-fiber neuropathy in skin conditions and the role of Kv1 channels in counterbalancing hyperexcitability in neuropathic pain. She takes a translational approach ranging from in vitro models to human psychophysics. The National Commission for Scientific and Technological Research in Chile funds her work. Dr. Calvo is part of the pain unit at the university hospital, where she sees neuropathic pain patients.

Mary Cardosa, MBBS, is a visiting consultant pain specialist at Hospital Selayang, Selangor, Malaysia. She obtained a master's in anesthesiology from the University of Malaya in 1991, FANZCA in 1993, and FFPMANZCA in 1999. After completing her pain fellowship at the Pain Management and Research Center, Royal North Shore Hospital, Sydney, Australia, she returned to Malaysia to set up the first multidisciplinary pain clinic in Selayang Hospital in 2000, the first in the Ministry of Health (MOH). She went on to do further pioneering work in developing pain services in Malaysia, starting the first cognitive behavior therapy-based pain management program in Southeast Asia in Selayang Hospital in 2002. Dr. Cardosa has been responsible for training many other pain specialists in Malaysia, and was the key person in the implementation of “Pain as the 5th Vital Sign” and “Pain Free Hospital” programs in the Malaysian MOH. She is president of the Malaysian Association for the Study of Pain (MASP) and a Council member of the International Association for the Study of Pain. She is also past president of the Malaysian Medical Association, the Malaysian Society of Anaesthesiologists, and the Malaysian College of Anaesthesiologists. 

Christine Chambers, PhD, RPsych, is the Canada Research Chair (Tier 1) in Children’s Pain, and a professor in the Department of Pediatrics, and the Department of Psychology and Neuroscience, at Dalhousie University in Halifax, Nova Scotia, Canada. Her research lab is based in the Centre for Pediatric Pain Research at the IWK Health Centre. She has published over 100 peer-reviewed papers on the role of developmental, psychological, and social influences on children’s pain, with a current research focus on the role of families in pediatric pain and social media for health knowledge mobilization. She is the 2016 recipient of the American Pain Society’s Jeffrey Lawson Award for Advocacy in Children’s Pain Relief and the Canadian Pain Society and Canadian Pain Coalition’s Pain Awareness Award.

Dawn Ehde, PhD, is a clinical psychologist and holds the Nancy and Buster Alvord Endowed Professorship in Multiple Sclerosis Research in the Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, US. Via research funded by the National Institutes of Health, the Patient Centered Outcomes Research Institute, the Department of Defense, and other sources, she has conducted multiple randomized controlled trials evaluating behavioral, pharmacologic, and exercise interventions for pain, depression, and fatigue in persons with chronic neurologic conditions such as multiple sclerosis and traumatic brain injury. She has a particular interest in alternative care delivery models, including telehealth, for improving access to evidence-based pain care and integrating non-pharmacologic interventions for chronic pain into healthcare. She is the Editor-in-Chief of Rehabilitation Psychology and Section Editor of Archives of Physical Medicine and Rehabilitation.  

Howard Fields, MD, PhD, is a professor of neurology and physiology emeritus at the University of California, San Francisco, US (UCSF). Dr. Fields was a founder of the UCSF Pain Management Center and has made major contributions to understanding and treating post-herpetic neuralgia, including demonstrating the effectiveness of opioids and topical lidocaine for neuropathic pain. In laboratory studies he discovered a pain-modulating neural circuit that engages endogenous opioids and is activated by opioid analgesics. His group also discovered that pain relief from placebo administration can be blocked by an opioid antagonist, opening the way to a neurobiological explanation of placebo analgesia. His recent work has centered on the problem of addiction. His team has discovered nerve cells in the striatum that selectively encode the magnitude of a reward, and shown how opioid control of the neurotransmitter dopamine contributes to motivation and reward-based choice. Dr. Fields is a member of the US National Academy of Medicine (formerly called the Institute of Medicine) and the American Academy of Arts and Sciences.

Kathleen Foley, MD, is an attending neurologist emeritus at Memorial Sloan Kettering Cancer Center in New York City and is a professor emeritus of neurology, neuroscience and clinical pharmacology at Weill Medical College of Cornell University. She held the Chair of the Society of Memorial Sloan Kettering Center in Pain Research and served as the chief of the Pain Service at MSKCC. She is the past director of MSKCC's WHO Collaborating Center in Cancer Pain Research and Education and chaired three WHO expert committees that resulted in the publication of three WHO monographs on cancer pain and palliative care in 1986, 1990 and 1996. She also directed the Open Society Foundation's Project on Death in America, a nine-year, 45 million dollar effort, to transform the culture of dying in the US and served as the medical director of OSF's International Palliative Care Initiative, which funded international efforts to advance palliative care in low- and middle- income countries. Dr.Foley is a member of the National Academy of Medicine, a past president of the American Pain Society and past IASP council member and WHO liaison for IASP. Dr. Foley has received numerous awards and honors for her work including the Medal Of Honor from the American Cancer Society, the David Karnofsky Award from the American Society of Clinical Oncology and the Frank Netter Award from the American Academy of Neurology. 

Sandrine Géranton, PhD, is a lecturer in molecular neuroscience in the Department of Cell and Developmental Biology at University College London (UCL), UK. She studied organic chemistry and biochemistry at the École Nationale Supérieure de Chimie de Montpellier in France. After earning an MSc in biotechnology, she joined UCL, where she earned a PhD in the then-Department of Pharmacology. She went on to learn about pain mechanisms as a postdoctoral researcher with the London Pain Consortium in the Department of Cell and Developmental Biology at UCL, where she is now a lecturer. Dr. Géranton has always been keen on applying her multidisciplinary background to further her understanding of the molecular biology of pain states, and has been at the forefront of the investigation of the role of epigenetic mechanisms in the development of pain states.

Babita Ghai, MD, is a professor of anesthesia and consultant in charge of the pain clinic at the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. She was awarded a clinical commonwealth academic staff fellowship in pain management at Barts and London NHS trust, London, UK, in 2012. She has more than 22 years of post-MD experience with a keen interest in pain management, pain education, pain research, and policy creation. She focuses on both acute and chronic pain, with a main interest in low back pain and neuropathic pain. Dr. Ghai is also a member of the International Association for the Study of Pain (IASP) Developing Countries Working Group, and is also a group member of the task force for the 2018 IASP Global Year for Excellence in Pain Education, representing developing countries to produce an evidence-based educational resource for teachers to improve educational delivery. She received an IASP Developing Country Education Grant in 2014-2015 to provide pain education to undergraduate nursing students. She has also served as joint secretary of the Indian Society for the Study of Pain (ISSP) and as an editorial board member of the Indian Journal of Pain. She is also chair of the ISSP interventional pain SIG. Dr. Ghai is an expert group member for national pain guideline development and for the national pain program. 

 

Ru-Rong Ji, PhD, is a Distinguished Professor, Chief of Pain Research, and Co-Director of the Center for Translational Pain Medicine at Duke University Medical Center in Durham, North Carolina, US. Previously he was an associate professor at Brigham and Women’s Hospital and Harvard Medical School, Boston, US. His research focuses on how glial cells and neuroinflammation are involved in the pathogenesis of neuropathic and inflammatory pain. Dr. Ji is well known for his contributions to understanding the roles of MAP kinase signaling in chronic pain, and recently he and his colleagues demonstrated analgesic effects from the inflammation-resolving lipid mediators resolvins and neuroprotectins.

Eija Kalso, MD, DMedSci, is the Signe and Ane Gyllenberg Professor of Pain Medicine at the University of Helsinki, Finland, and a visiting professor at the Karolinska Institute, Stockholm, Sweden. She is a past president of the International Association for the Study of Pain (IASP). Dr. Kalso has also been the field editor for clinical science at PAIN, the journal of IASP, and at the European Journal of Pain. Dr. Kalso is trained in anesthesiology and also received special competence in pain management. Her main research interests include opioid pharmacology, spinal mechanisms of nociception, cancer pain, clinical trial design and evidence-based medicine, persistent postsurgical pain, and the genetics of pain. She currently coordinates the European Union FP7 project GLORIA, which focuses on the role of glia in various types of pain and in opioid tolerance and hyperalgesia, including two different lines of drug development.

Hellen Kariuki, PhD, is a medical physiologist with a background in dental surgery. She is a senior lecturer in the Department of Medical Physiology at the University of Nairobi Medical School in Kenya. She is involved in the teaching and training of healthcare workers from all the healthcare disciplines in the College of Health Sciences, where she also serves on the college curriculum and postgraduate committees. She is involved in pain education and has spearheaded pain and pain management trainings and workshops in Kenya, which have trained over 1,000 healthcare workers from all disciplines. Dr. Kariuki serves on the Kenyan Opioid Availability Task Force and has also been involved in curriculum development and clinical guidelines on palliative care for the Ministry of Health. In collaboration with others, she is developing the pain and regional anesthesia fellowship curriculum for Kenya. She also serves as a director at Metropolitan Hospital, Nairobi, Kenya. She served as a member of the IASP Education Initiative Working Group (2010-2016). She is an IASP Council member and a member of the committee for the Global Year for Excellence in Pain Education. She served as the secretary general for the Kenya Society for Pain (an IASP chapter) and is the current chair. 

Fusao Kato, MD, PhD, is a full professor at Jikei University School of Medicine in Tokyo, Japan, where he is also director of the Department of Neuroscience and chairman of the Center for Neuroscience of Pain. He was vice president of the Physiological Society of Japan and the deputy editor of Molecular Pain. He is also a member of the Science Council of Japan, a board member of the Japanese Association for the Study of Pain, the Japanese Pharmacological Society, and the Japan Society of Neurovegetative Research. Dr. Kato’s research subjects include synaptic plasticity in the link between nociception and emotion in the amygdala and pain network, astrocyte-neuron interaction at synapses, synaptic transmission regulation in the central autonomic network, cellular and synaptic mechanisms underlying motor neuron vulnerability, and cellular and synaptic mechanisms of anesthetic effects.

Jeffrey Mogil, PhD, is the E. P. Taylor Professor of Pain Studies and the Canada Research Chair in the Genetics of Pain at McGill University in Montreal, Canada. He has made seminal contributions to the field of pain genetics and has written many reviews on the subject. He is the editor of The Genetics of Pain (IASP Press, 2004). Dr. Mogil also studies sex differences in pain and analgesia, and is known for developing pain testing methods in the laboratory mouse. He was the neurobiology section editor for the journal PAIN and was chair of the Scientific Program Committee of the 2010 13th World Congress on Pain. Dr. Mogil is a recipient of the Patrick D. Wall Young Investigator Award from IASP, and in 2013 he won the Frederick W.L. Kerr Basic Science Research Award from the American Pain Society.

Anne Louise Oaklander, MD, PhD, is an associate professor of neurology at Harvard Medical School and an assistant in pathology at Massachusetts General Hospital in Boston, US, where she directs the Nerve Unit and the Neurodiagnostic skin biopsy laboratory. Her research laboratory characterizes neurological sensory disorders that cause chronic pain and itch. They were among the first to identify nerve injuries in patients with complex regional pain syndrome type I and they developed and characterized a rodent model of CRPS-I. They discovered a new small-fiber polyneuropathy that causes disabling multi-symptom illnesses in young people, and that small-fiber polyneuropathy underlies 40% of fibromyalgia cases. They proposed that some small-fiber neuropathies are autoimmune and published the first study of efficacy of immunotherapy.  

Romy Parker, PhD, is an associate professor in the Department of Anaesthesia and Perioperative Medicine at the University of Cape Town, South Africa. She has a background in physiotherapy and specializes in pain management. Dr. Parker is an active researcher, rated C3 by the South African National Research Foundation, who has successfully supervised numerous postgraduate students. She is the course convener of the Postgraduate Diploma in Interdisciplinary Pain Management, the first program of its kind in Africa. She is an experienced clinician working in chronic pain management as part of the Chronic Pain Management Unit of Groote Schuur Hospital. Her research focuses on pain with emphasis on developing and testing mechanism-based treatments relevant to a South African context. She is the current president of PainSA (the South African chapter of the International Association for the Study of Pain), and the past chair of the Pain, Mind and Movement Special Interest Group of IASP.

Esther Pogatzki-Zahn, MD, PhD, is an anesthesiologist, pain specialist, and full professor in the Department of Anesthesiology, Intensive Care and Pain Medicine at University Hospital Muenster, Germany. Her main clinical work is in pain management (acute, chronic, and palliative). She has a PhD in neuroscience (1998-2003) from the US and now runs a basic science research lab at the University of Muenster, Germany. Dr. Pogatzki-Zahn’s research group is aiming to provide insight into the neuropathology of incisional, chronic inflammatory, neuropathic, and cancer-related pain. In addition to basic science studies, she performs translational research by using human surrogate models of pain and itch in volunteers and patients. Finally, she performs clinical studies and is involved in a number of international multicenter projects like Pain-Out, IMI-PAINCARE, and other large, international, multicenter consortia. She is a member of the Prospect Initiative and the DFNS e.V. She is also part of several “pain” boards and councils, including the IASP acute pain SIG (currently chair), the European Society of Anesthesiologists, the IASP Council (2018-2024), and the council board of the German Pain Society.    

 

Frank Porreca, PhD, is a professor of pharmacology and anesthesiology at the University of Arizona, Tucson, US. Dr. Porreca is interested in approaches that may allow measurement and mechanistic evaluation of affective dimensions of pain in animal models. His research focuses on the role of descending modulatory circuits in chronic pain states, the mechanisms by which opioids and stress engage these circuits, and the discovery of molecules that can modulate these circuits. Recently he has worked on understanding intersections between pain and reward pathways in injury-related and functional pain models. Dr. Porreca has received numerous awards including the Frederick W.L. Kerr Basic Science Research Award from the American Pain Society, the Ronald Melzack Award from the International Association for the Study of Pain, and the P.D. Wall Award from the British Pain Society. 

Stephan Schug, MD, is a professor and chair of anaesthesiology and pain medicine in the medical school of the University of Western Australia, and director of pain medicine at Royal Perth Hospital in Australia. His principal research interests include the management of acute and chronic pain, cancer pain, regional anesthesia, the pharmacology of local anesthetics and analgesics, and quality improvement in healthcare. He studied medicine at the University of Cologne, Germany, where he also obtained his MD in clinical pharmacology and subsequently specialized in anesthesia and pain medicine. He is currently on editorial and review boards of several leading journals including Pain and Therapy, Annals of Palliative Medicine, Current Opinion in Anaesthesiology, and CNS Drugs. He is an active member of several pain and anesthesia societies including as past chair of the International Association for the Study of Pain acute pain SIG and chair of the ACE acute pain SIG. He is a Fellow of the Australian and New Zealand College of Anaesthetists (ANZCA) and its Faculty of Pain Medicine (FPMANZCA), where he is a member of the board of the faculty. 

Petra Schweinhardt, MD, PhD, is the head of research of the Department of Chiropractic Medicine at the Balgrist University Hospital and the University of Zurich, Switzerland. Her clinical research is focused on outcomes in patients with musculoskeletal pain treated by chiropractors and potential predictors of treatment outcome. In her experimental work, she investigates how sensitization in the central nervous system contributes to musculoskeletal pain. Methods she uses include psychophysics, kinematic modeling, and brain imaging. Before moving to Switzerland, Dr. Schweinhardt held an associate professorship and a Canada Research Chair Tier II at McGill University in Montreal, Canada, where her research centered on cerebral pain processing and modulation as well as brain alterations in chronic pain patients. She earned her medical degree at Ruprecht-Karls-Universität in Heidelberg, Germany, and a PhD in the neurosciences at the University of Oxford, UK. 

 

Rebecca Seal, PhD, is an associate professor in the Department of Neurobiology, Department of Otolaryngology, and the Pittsburgh Center for Pain Research at the University of Pittsburgh School of Medicine, US. She received her PhD training at the Vollum Institute, Oregon Health and Sciences University, Portland, US, and her postdoctoral training in the Department of Neurology at the University of California, San Francisco, US. Her laboratory investigates spinal pain circuits and is developing novel therapeutics. She has been the recipient of awards from the Rita Allen Foundation, American Pain Society, Brain and Behavior Research Foundation, American Diabetes Association, and Whitehall Foundation.

Claudia Sommer, MD, is a professor of neurology at the University of Würzburg, Germany. She received training in psychiatry, neuropathology, experimental anesthesia, and neurology. She is president elect of the International Association for the Study of Pain (IASP). At the University of Würzburg, she serves as a consultant in neurology, organizes an outpatient clinic for patients with pain, and leads the Peripheral Nerve Laboratory. With her research group, she investigates the role of immune mediators in the pathophysiology of pain, the improvement and standardization of diagnostics in neuropathies, and the pathophysiology of antibody-mediated diseases. Dr. Sommer is active in the development of national and international guidelines on treatment of peripheral neuropathies, on nerve and skin biopsies, and on treatment of fibromyalgia and neuropathic and facial pain.

 

Hiroshi Ueda, PhD, is a professor at Nagasaki University, Institute of Biomedical Sciences, Japan. He received his PhD from Kyoto University and has been interested in opioid and pain research for many years. He was an International Association for the Study of Pain (IASP) Councilor (2010-2016) and has worked for many IASP committees. His major work on pain and opioids includes the discovery of kyotorphin, a Met-enkephalin releaser, successful reconstitution of purified mu-opioid receptors and G proteins, identification of lysophosphatidic acid (LPA) as an initiator of neuropathic pain, and epigenetic regulation of neuropathic pain. He is currently interested in the molecular mechanisms of centralized pain (fibromyalgia), and is doing translational research.

 

 

We thank our previous editorial board members, Lars Arendt-Nielsen, Dr Med Sci., PhD; David Bennett, MB, PhD; Marshall Devor, PhDChristopher Eccleston, PhD; Rohini Kuner, PhD; Joseph Martin, MD, PhD; Stephen McMahon, PhD; Judith Turner, PhD; William Schmidt, PhD; and Clifford Woolf, MD, PhD. Their guidance helped grow PRF into the thriving web community it is today. We also thank our 2014-2016 webinar advisory panel members, Chas Bountra, PhD; Iain Chessell, PhD; Carole Ho, MD; Charles Inturrisi, PhD; Stephen McMahon, PhD; Joseph V. Pergolizzi, Jr., MD; Robert B. Raffa, PhD; and William Schmidt, PhD.